Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug
The depth and versatility of siRNA technologies enable their use in disease targets that are undruggable by small molecules or that seek to achieve a refined turn-off of the genes for any therapeutic area. Major extracellular barriers are enzymatic degradation of siRNAs by serum endonucleases and RN...
Saved in:
Main Authors: | Danielle de Brito e Cunha (Author), Ana Beatriz Teixeira Frederico (Author), Tamiris Azamor (Author), Juliana Gil Melgaço (Author), Patricia Cristina da Costa Neves (Author), Ana Paula Dinis Ano Bom (Author), Tatiana Martins Tilli (Author), Sotiris Missailidis (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
siRNA Therapeutics: From Bench Lab. to Clinics
by: Cristina Romero-López, et al.
Published: (2024) -
Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
by: Muhammad Imran Sajid, et al.
Published: (2020) -
Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
by: Chiranjib Chakraborty, et al.
Published: (2017) -
Thermal Stability of siRNA Modulates Aptamer- conjugated siRNA Inhibition
by: Alexey Berezhnoy, et al.
Published: (2012) -
Antibody-siRNA conjugates (ARC): Emerging siRNA drug formulation
by: Weiran Cao, et al.
Published: (2022)